[CAS NO. 108524-94-3]  Ilexgenin A

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [108524-94-3]

Catalog
HY-N6255
Brand
MCE
CAS
108524-94-3

DESCRIPTION [108524-94-3]

Overview

MDL-
Molecular Weight502.68
Molecular FormulaC30H46O6
SMILESC[C@@]12C([C@@]3([H])[C@@](CC2)(CC[C@H]([C@]3(O)C)C)C(O)=O)=CC[C@@]4([H])[C@]1(CC[C@]5([H])[C@@]4(CC[C@@H]([C@]5(C)C(O)=O)O)C)C

For research use only. We do not sell to patients.

Summary

Ilexgenin A is a pentacyclic triterpenoid, which extracted from Ilex hainanensis Merr. Ilexgenin A can be used for the research of inflammation and cancer [1] .


In Vitro

Ilexgenin A (0~100 μM; 24 hours; HT 29 and HCT 116 cells) effectively decreases cell viability in HT 29 and HCT 116 cells [1] .
Ilexgenin A (12.5~50 μM; 24 hours; HT 29 cells) downregulates the expression of SREBP-1, inhibits the translocation of SREBP-1 to the nucleus and decreases the content of TG [1] .
Ilexgenin A (12.5~50 μM; HT 29 and HCT 116 cells) induces cell cycle arrest at G1 phase in colon cancer cells [1] .
Ilexgenin A (12.5~50 μM; 24 hours; HCT 116 cells) modulates lipid metabolism. Ilexgenin A (50 μM; 24 hours; HT 29 and HCT 116 cells) regulates SREBP-1 by inhibiting HIF1α [1] .
Ilexgenin A inhibits fatty acids synthesis [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay [1]

Cell Line: HT 29 and HCT 116 cells
Concentration: 0~100 μM
Incubation Time: 24 hours
Result: Effectively decreased cell viability in HT 29 and HCT 116 cells.

Western Blot Analysis [1]

Cell Line: HT 29 cells
Concentration: 12.5~50 μM
Incubation Time: 24 hours
Result: Downregulated the expression of SREBP-1.

RT-PCR [1]

Cell Line: HT 29 cells
Concentration: 12.5~50 μM
Incubation Time: 24 hours
Result: Decreased the content of TG.

Immunofluorescence [1]

Cell Line: HT 29 cells
Concentration: 12.5~50 μM
Incubation Time: 24 hours
Result: Inhibited the translocation of SREBP-1 to the nucleus.

In Vivo

Ilexgenin A (20 mg/kg) ameliorates the AOM/DSS induced carcinogenesis. Ilexgenin A can regulate lipid metabolism. Ilexgenin A decreases the expression of SREBP-1 and HIF 1α in AOM/DSS mice [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


Appearance

Solid



Shipping

Room temperature in continental US; may vary elsewhere.


Storage

4°C, protect from light

* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)


Solvent & Solubility

In Vitro:

DMSO : 100 mg/mL ( 198.93 mM ; Need ultrasonic)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 1.9893 mL 9.9467 mL 19.8934 mL
5 mM 0.3979 mL 1.9893 mL 3.9787 mL
10 mM 0.1989 mL 0.9947 mL 1.9893 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

    Solubility: 2.5 mg/mL (4.97 mM); Suspended solution; Need ultrasonic

  • 2.

    Add each solvent one by one: 10% DMSO >> 90% corn oil

    Solubility: ≥ 2.5 mg/mL (4.97 mM); Clear solution

* All of the co-solvents are available by MCE.


Synonyms

Urs-12-ene-23,28-dioic acid, 3,19-dihydroxy-, (3β,4β)-
(3β,4β)-3,19-Dihydroxyurs-12-ene-23,28-dioic acid
Myriaboric acid
Ilexgenin A
Ilicin A
Llexgenin A